News for VVUS
HEALTHCARE FIRMS, INVESTORS TO MEET AT CRUTTENDEN ROTH NEW YORK CONFERENCE
List of Presenting Companies
New Format Will Tie Presentations to Topical Industry Issues
IRVINE, Calif., June 4 /PRNewswire/ -- Emerging growth companies in
the biomed, medical devices and healthcare industries and Wall Street
investors and analysts will come together at the Cruttenden Roth
Healthcare Conference, scheduled June 29-30 at the St. Regis Hotel in
New York City.
Entitled "Outsourcing Strategies: A Path to Disease Management," the
conference will depart from the traditional investor conference format.
Each presenting company will be grouped to follow one of the following
tracks: Oncology; Drug Delivery; Research Outsourcing;
Pharmacogenomics/Information Technology; Disease and Condition
Management; Cost Containment/Outsourcing; or Biopharmaceutical/Medical
Products.
A 30-minute industry overview will be followed by a thematic
presentations by the respective analyst of each track. Presenting
companies will then follow with presentations supporting that theme.
Cruttenden Roth, a Western US-based underwriter specializing in
emerging growth companies, sponsors this conference to provide small
cap healthcare companies an opportunity to meet one-on-one with Wall
Street investors and analysts. It is also intended to provide
investors a most efficient way to meet a large number of companies at
one time and in one place.
Featured luncheon speakers include: Professor, Dr. Jurgen Drews, former
President of Global Research at Hoffmann-La Roche Inc. who will address
"Strategic Options for the Pharmaceutical Industry at the Turn of the
Century." Also, Jim L. Kearns, Marketing Director, Health Technology
Initiatives -- Intel Corporation will speak on "The Connected PC as a
Disruptive Force in Healthcare."
Co-sponsors of this year's conference include Bowne financial printers;
Healthcare Business Media; Investors Business Daily; and PR Newswire;
and the law firms of Stradling Yocca Carlson & Rauth, and Stroock &
Stroock & Lavan.
Institutional investors, financial advisors, analysts, portfolio
managers, and Cruttenden Roth clients will be hosted. For registration
information contact Cruttenden Roth's conference desk: (949) 757-5786.
Cruttenden Roth is a national investment bank and brokerage
specializing in emerging growth companies. The most active underwriter
in the under $100-million offering size, the firm has won recognition
as one of the best performing underwriters in the nation, based on
aftermarket performance. Headquartered in Irvine, California, the
Company maintains regional offices throughout the US. It is a member
of the National Association of Securities Dealers (NASD), the
Securities Industry Association (SIA), and the Securities Investor
Protection Corporation (SIPC).
Media Contact: Nevena Orbach (The Orbach Company, Inc.) 818-904-0500
CRUTTENDEN ROTH HEALTHCARE CONFERENCE
"Outsourcing Strategies: A Path to Disease Management"
June 29-30, 1998 -- The St. Regis, New York
Preliminary list of presenting companies and speakers (subject to change)
BIOPHARMACEUTICAL
Alliance Pharmaceutical Corporation (ALLP) San Diego, CA
Cypros Pharmaceutical Corporation (CYP) Carlsbad, CA
GelTex Pharmaceuticals, Inc. (GELX) Waltham, MA
LXR Biotechnology Inc. (LXR) Richmond, CA
Kimeragen Newtown, PA
Tanox Biosystems, Inc. Houston, TX
COST CONTAINMENT/OUTSOURCING/MEDICAL PRODUCTS
CompuCyte Corporation Cambridge, MA
InnerDyne, Inc. (IDYN) Sunnyvale, CA
IntegraMed America, Inc. (INMD) Purchase, NY
Invivo Corporation (SAFE) Pleasanton, CA
Molecular Biosystems, Inc. (MB) San Diego, CA
National Healthcare Mfg. Corp. (NHMCF) Winnipeg, Manitoba
Premier Research Worldwide, Ltd. (PRWW) Philadelphia, PA
PrISMedical Corporation Napa, CA
SONUS Pharmaceuticals, Inc. (SNUS) Bothell, WA
Thoratec Laboratories Corporation (THOR) Pleasanton, CA
DISEASE & CONDITION MANAGEMENT
Curative Health Services, Inc. (CURE) Hauppauge, NY
Matria Healthcare, Inc. (MATR) Marletta, GA
Pediatrix Medical Group, Inc. (PDX) Ft. Lauderdale, FL
PMR Corporation (PMRP) San Diego, CA
PolyMedica Corporation (PM) Woburn, MA
DRUG DELIVERY
Advanced Polymer Systems, Inc. (APOS) Redwood City, CA
Alkermes, Inc. (ALKS) Cambridge, MA
Anesta Corporation (NSTA) Salt Lake City, UT
Aradigm Corporation (ARDM) Hayward, CA
DepoMed, Inc. (DPMD) Foster City, CA
Emisphere Technologies, Inc. (EMIS) Hawthorne, NY
FeRx, Inc. San Diego, CA
Fuisz Technologies Inc. (FUSE) Chantilly, VA
Inhale Therapeutic Systems (INHL) San Carlos, CA
Transkaryotic Therapies, Inc. (TKTX) Cambridge, MA
VIVUS, Inc. (VVUS) Mountain View, CA
HEALTHCARE INFORMATION SYSTEMS
Hooper Holmes, Inc. (HH) Basking Ridge, NJ
InfoCure Corporation (INC) Atlanta, GA
Medirisk, Inc. (MDMD) Atlanta, GA
MedQuist, Inc. (MEDQ) Marlton, NJ
StorCOMM, Inc. San Diego, CA
ONCOLOGY
Cell Therapeutics, Inc. (CTIC) Seattle, WA
Corixa Corporation (CRXA) Seattle, WA
Genetronics, Inc. (GEB CN) San Diego, CA
IDEC Pharmaceuticals Corporation (IDPH) San Diego, CA
ImClone Systems, Inc. (IMCL) New York, NY
Introgen Therapeutics, Inc. Austin, TX
Maxim Pharmaceuticals, Inc. (MMP) San Diego, CA
Medarex, Inc. (MEDX) Annandale, NJ
NeoRx Corporation (NERX) Seattle, WA
North American Scientific, Inc. (NASI) N. Hollywood, CA
Targeted Genetics Corporation (TGEN) Seattle, WA
Theragenics Corporation (THRX) Norcross, GA
Titan Pharmaceuticals, Inc. (TTNP) S. San Francisco, CA
Vion Pharmaceuticals, Inc. (VION) New Haven, CT
PHARMACOGENOMICS/INFORMATION TECH.
Affymetrix, Inc. (AFFX) Santa Clara, CA
Digital Gene Technologies La Jolla, CA
Oncormed, Inc. (ONM) Gaithersburg, MD
Oncotech, Inc. Irvine, CA
Variagenics, Inc. Cambridge, MA
Visible Genetics, Inc. (VGINF) Toronto, Ontario
RESEARCH OUTSOURCING
Axiom Biotechnologies, Inc. San Diego, CA
Cadus Pharmaceutical Corporation (KDUS) Tarrytown, NY
Chromagen, Inc. San Diego, CA
EnzyMed, Inc. Iowa City, IA
Ontogeny, Inc. Cambridge, MA
OSI Pharmaceuticals, Inc. (OSIP) Uniondale, NY
KEYNOTE SPEAKERS
Monday, June 29 Tuesday, June 30
Professor Dr. Jurgen Drews, Ph.D. Jim L. Kearns
Formerly President of Global Research Marketing Director,
Health Hoffmann-La Roche Inc Technology Initiatives
-- Intel Corporation
Topic: Strategic Options for the Pharmaceutical Topic: The
Connected PC as Industry at the Turn of the Century
Disruptive Force in
Healthcare
SOURCE Cruttenden Roth
|
